Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-014315
Filing Date
2025-02-14
Accepted
2025-02-14 17:17:32
Documents
1
Period of Report
2025-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm256716-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm256716-4_4seq1.xml 4 4416
  Complete submission text file 0001104659-25-014315.txt   6173
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2925 RICHMOND AVENUE SUITE 1274 HOUSTON TX 77098
Business Address
Vera Juan (Reporting) CIK: 0001755495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 25630952